These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 23792088

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ, Tschöpe C.
    J Am Coll Cardiol; 2013 Jul 23; 62(4):263-71. PubMed ID: 23684677
    [Abstract] [Full Text] [Related]

  • 3. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
    From AM, Borlaug BA.
    Cardiovasc Ther; 2011 Aug 23; 29(4):e6-21. PubMed ID: 20370792
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S, Thunström E, Johansson MC, Fu M.
    Int J Cardiol; 2017 Apr 01; 232():86-92. PubMed ID: 28100428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP, TIME-CHF Investigators.
    Eur J Heart Fail; 2013 Oct 01; 15(10):1148-56. PubMed ID: 23657728
    [Abstract] [Full Text] [Related]

  • 9. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A, Goncalvesova E, Janssens S, Katova T, Køber L, Lelonek M, Linssen G, Lund LH, O'Meara E, Merkely B, Milicic D, Oh BH, Perrone SV, Ranjith N, Saito Y, Saraiva JF, Shah S, Seferovic PM, Senni M, Sibulo AS, Sim D, Sweitzer NK, Taurio J, Vinereanu D, Vrtovec B, Widimský J, Yilmaz MB, Zhou J, Zweiker R, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV.
    Circ Heart Fail; 2018 Jul 01; 11(7):e004962. PubMed ID: 29980595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH, Benson L, Dahlström U, Edner M.
    JAMA; 2012 Nov 28; 308(20):2108-17. PubMed ID: 23188027
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
    van Heerebeek L, Hamdani N, Falcão-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ.
    Circulation; 2012 Aug 14; 126(7):830-9. PubMed ID: 22806632
    [Abstract] [Full Text] [Related]

  • 16. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
    Verbrugge FH, Duchenne J, Bertrand PB, Dupont M, Tang WH, Mullens W.
    Am J Cardiol; 2013 Dec 15; 112(12):1913-20. PubMed ID: 24286620
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").
    Hogg K, McMurray J.
    Heart Fail Rev; 2006 Jun 15; 11(2):141-6. PubMed ID: 16937033
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heart failure with preserved ejection fraction: current understanding and emerging concepts.
    Liu Y, Haddad T, Dwivedi G.
    Curr Opin Cardiol; 2013 Mar 15; 28(2):187-96. PubMed ID: 23274284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.